Prevention of Severe Ovarian Cancer courses — what to do?

Ovarian cancer, a rare gynecological cancer, the causes of which are largely unknown.

How can a society, how can each individual position themselves?

Information

Around 7,500 women per year deve­lop ova­ri­an can­cer in Ger­ma­ny every year, but this dise­a­se is com­ple­te­ly unknown to most of tho­se affec­ted and their fami­lies. The qua­li­ty of the tre­at­ment has a direct influence on the pro­gno­sis of the dise­a­se, both sur­gi­cal and drug the­ra­py is meant here. The invol­vement in cli­ni­cal stu­dies is also a gua­ran­tee for the qua­li­ty and com­pe­tence of the the­ra­pists and offers tho­se affec­ted addi­tio­nal inno­va­ti­ve tre­at­ment options. 

Nevert­hel­ess, the cur­rent invol­vement of tho­se affec­ted in Ger­ma­ny is com­ple­te­ly unsa­tis­fac­to­ry. The Ova­ri­an Can­cer Foun­da­ti­on works to ensu­re that pati­ents and their rela­ti­ves as well as all tho­se invol­ved in the health sys­tem are bet­ter and more spe­ci­fi­cal­ly infor­med about this dise­a­se.
More infor­ma­ti­on under Infor­ma­ti­on mate­ri­al, Events and Ova­ri­an can­cer.

Educate

Informing tho­se affec­ted with ova­ri­an can­cer about all tre­at­ment opti­ons and their alter­na­ti­ves with all their effects on the pro­gno­sis but also on per­so­nal life in ever­y­day life is the indis­pensable basis for any the­ra­py decis­i­on.
The­re are con­sidera­ble defi­ci­ts here for various reasons. The Ova­ri­an Can­cer Foun­da­ti­on works to ensu­re that the edu­ca­ti­on of pati­ents and their rela­ti­ves about the dise­a­se and the indi­vi­du­al tre­at­ment steps is signi­fi­cant­ly impro­ved. More infor­ma­ti­on under Infor­ma­ti­on mate­ri­al, Events and Ova­ri­an can­cer.

Strengthen research

In recent years, the tre­at­ment results for ova­ri­an can­cer have impro­ved signi­fi­cant­ly on the basis of stu­dies, but the long-term results for women with ova­ri­an can­cer are still unsa­tis­fac­to­ry. The majo­ri­ty of women with ova­ri­an can­cer are only reco­gni­zed at an advan­ced stage of the tumor and die of the dise­a­se. For this reason, rese­arch acti­vi­ties in the field of ova­ri­an can­cer must be decisi­ve­ly inten­si­fied; both pre­cli­ni­cal and cli­ni­cal rese­arch pro­jects must be desi­gned.
The Ova­ri­an Can­cer Foun­da­ti­on works to ensu­re that inno­va­ti­ve rese­arch pro­jects on tumor bio­lo­gy, dia­gno­stics, the­ra­py and after­ca­re are sys­te­ma­ti­cal­ly fun­ded. More infor­ma­ti­on at: www.studienportal-eierstockkrebs.de and www.noggo.de

More information: